N-Acetylserotonin Alleviates Retinal Autophagy via TrkB/AKT/Nrf2 Signaling Pathway in Retinal Ischemia-Reperfusion Injury Rats
Ophthalmic Research · 2024
DOI: 10.1159/000535786 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ophthalmic Research, 2024. Verfasst von Luming Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Imaging, Weifang Medical University, Weifang, China. Hauptthemen laut MEDLINE: Retinal Diseases, Reperfusion Injury. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The objective of this study was to investigate the impact of N-acetylserotonin (NAS) on the autophagy of retinal cells in rats with retinal ischemia-reperfusion injury (RIRI) and to explore the mechanisms by which NAS administration can alleviate RIRI through the tropomyosin-related kinase receptor B (TrkB)/protein kinase B (Akt)/nuclear factor erythroid-derived factor 2-related factor (Nrf2) signaling pathway.
Methods
Healthy adult male rats were randomly assigned to four groups: sham, RIRI, RIRI+NAS, and RIRI+NAS+ANA-12. The RIRI group was induced by elevating intraocular pressure, and changes in retinal structure and edema were assessed using H&E staining. The RIRI+NAS and RIRI+NAS+ANA-12 groups received intraperitoneal injections of NAS before and after modeling. The RIRI+NAS+ANA-12 group was also administered ANA-12, a TrkB antagonist. Immunohistochemical staining and Western blot analysis were used to evaluate phosphorylated TrkB (p-TrkB), phosphorylated Akt (p-Akt), Nrf2, sequestosome 1 (P62), and microtubule-associated protein 1 light chain 3 (LC3-II) levels in the retinas of each group. Electroretinogram was recorded to detect retinal function in each group of rats 24 h after modeling.
Results
The RIRI+NAS group had a thinner retina and more retinal ganglion cells (RGCs) than RIRI and RIRI+NAS+ANA-12 groups (p < 0.05). Immunohistochemical staining and Western blot results showed that p-TrkB, p-Akt, n-Nrf2, and P62 levels in the RIRI+NAS group were higher compared with those in RIRI and RIRI+NAS+ANA-12 groups (p < 0.05). Also, lower LC3-II levels were observed in the RIRI+NAS group compared with that in RIRI and RIRI+NAS+ANA-12 groups (p < 0.05). Electroretinogram recording results showed that 24 h after retinal ischemia-reperfusion, the magnitude of b-wave changes was attenuated in the RIRI+NAS group compared with the RIRI group (p < 0.05).
Conclusion
The administration of NAS activates the TrkB/Akt/Nrf2 signaling pathway, reduces autophagy, alleviates retinal edema, promotes the survival of retinal ganglion cells (RGCs), and provides neuroprotection against retinal injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Imaging, Weifang Medical University, Weifang, China.
- Department of Ophthalmology, Affiliated Hospital of Weifang Medical University, Weifang, China.
- Harvard Medical School, Boston, Massachusetts, USA.
- Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
- Medical Imaging Center, Affiliated Hospital of Weifang Medical University, Weifang, China.
Zitieren
APA
Zhang, L., Gao, M., Zhao, Y., Yin, Y., Zhang, X., Zhou, S., Wang, X., Wang, X., & Zhao, Y. (2024). N-Acetylserotonin Alleviates Retinal Autophagy via TrkB/AKT/Nrf2 Signaling Pathway in Retinal Ischemia-Reperfusion Injury Rats. Ophthalmic Research. https://doi.org/10.1159/000535786
Vancouver
Zhang L, Gao M, Zhao Y, Yin Y, Zhang X, Zhou S, et al. N-Acetylserotonin Alleviates Retinal Autophagy via TrkB/AKT/Nrf2 Signaling Pathway in Retinal Ischemia-Reperfusion Injury Rats. Ophthalmic Research. 2024. doi:10.1159/000535786
BibTeX
@article{Zhang2024,
author = {Zhang, Luming and Gao, Meng and Zhao, Yuze and Yin, Yi and Zhang, Xuening and Zhou, Shuanhu and Wang, Xin and Wang, Xiaoli and Zhao, Yansong},
title = {N-Acetylserotonin Alleviates Retinal Autophagy via TrkB/AKT/Nrf2 Signaling Pathway in Retinal Ischemia-Reperfusion Injury Rats},
journal = {Ophthalmic Research},
year = {2024},
doi = {10.1159/000535786}
}
EUVIMED